Comorbidities and Age in Brain-Dead Donors and Liver Transplantation: A 15-Year Retrospective Investigation

Exp Clin Transplant. 2020 Feb;18(1):60-64. doi: 10.6002/ect.2019.0168. Epub 2019 Nov 13.

Abstract

Objectives: Although livers from older donors (> 70 y) have been shown to be increasingly more efficiently used for transplant, donor comorbidities are considered additional risk factors. This is quite intriguing as comorbidities are known to increase with advancing age in the donor population.

Materials and methods: We assessed whether age and donor comorbidities influenced liver procurement over a 15-year period in a cohort of 1702 brain-dead donors in Tuscany, Italy.

Results: Over the study period, age of potential donors significantly increased (P = .02) as well as the proportion of patients who were > 55 years old. The incidence of hypertension, diabetes mellitus, and previously known coronary artery disease also significantly increased. We observed a progressive increase in the number of transplanted livers from donors with advancing age despite an increase in comorbidities. The highest incidences of traumatic brain injury and anoxic brain injury were observed in the youngest donors. Transaminase levels and use of vasoactive drugs were lower in donors who were ≥ 72 years old.

Conclusions: According to our results, criteria for liver donors have already changed. Although age does not seem to be a limiting factor, older donors deserve a more accurate donor selection due to the higher incidence of risk factors (primarily diabetes mellitus).

Publication types

  • Observational Study

MeSH terms

  • Age Factors
  • Brain Death*
  • Brain Injuries / diagnosis
  • Brain Injuries / mortality*
  • Comorbidity
  • Coronary Artery Disease / epidemiology
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology*
  • Donor Selection*
  • Female
  • Humans
  • Hypertension / epidemiology
  • Incidence
  • Italy / epidemiology
  • Liver Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Tissue Donors*
  • Treatment Outcome